Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report

Center for Women's Mental Health, Massachusetts General Hospital, Boston, MA 02114, USA.
The Journal of Clinical Psychiatry (Impact Factor: 5.14). 06/2010; 71(6):669-81. DOI: 10.4088/JCP.10cs05959blu
Source: PubMed

ABSTRACT To review selected complementary and alternative medicine (CAM) treatments for major depressive disorder (MDD).
Authors of this report were invited participants in the American Psychiatric Association's Task Force on Complementary and Alternative Medicine.
The group reviewed the literature on individual CAM treatments for MDD, methodological considerations, and future directions for CAM in psychiatry. Individual CAM treatments were reviewed with regard to efficacy in MDD, as well as risks and benefits. Literature searches included MEDLINE and PsycINFO reviews and manual reference searches; electronic searches were limited to English-language publications from 1965 to January 2010 (but manual searches were not restricted by language). Treatments were selected for this review on the basis of (1) published randomized controlled trials in MDD and (2) widespread use with important clinical safety or public health significance relevant to psychiatric practice. An action plan is presented based on needs pertaining to CAM and psychiatry.
Consensus was reached by group conferences. Written iterations were drafted and sent out among group members prior to discussion, resolution of any differences of interpretation of evidence, and final approval.
A review of randomized controlled trials for commonly used CAM treatments such as omega-3 fatty acids, St John's wort (Hypericum), folate, S-adenosyl-L-methionine (SAMe), acupuncture, light therapy, exercise, and mindfulness psychotherapies revealed promising results. More rigorous and larger studies are recommended. Each CAM treatment must be evaluated separately in adequately powered controlled trials. At this time, several CAM treatments appear promising and deserve further study. The greatest risk of pursuing a CAM therapy is the possible delay of other well-established treatments. Clinical, research, and educational initiatives designed to focus on CAM in psychiatry are clearly warranted due to the widespread use of CAM therapies.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Migraine is frequently comorbid with major depressive disorder, the presence of which confers increased disability and various clinical challenges. The present article reviews empirically supported pharmacologic and cognitive-behavioral interventions for depression, as well as the emerging yet generally mixed efficacy for various complementary and alternative medicine depression treatments. Clinical implications and treatment strategies for migraine patients with comorbid depression are discussed. The literature reviewed here draws together clinical practice options for clinicians. © 2015 American Headache Society.
    Headache The Journal of Head and Face Pain 02/2015; 55(2). DOI:10.1111/head.12521 · 3.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background We extend findings from previous quantitative reviews of the effects of Tai Chi and Qigong exercises on symptoms of depression and anxiety in randomized controlled trials by examining whether effects varied according to participant characteristics, exposure, or features of research design. Methods Thirty-five articles published before 1 April, 2013 involving 2,765 participants were selected according to PRISMA guidelines. Hedges d effect sizes were calculated and random effects models were used to estimate population variance of the observed effects and its moderators using meta-regression analysis. Results Tai Chi training reduced depression by a heterogeneous standardized mean effect size 0.36 (95% CI, 0.19 to 0.53); reductions were larger in participants having elevated symptoms at baseline. Studies with blinded allocation of participants had smaller effects. The homogeneous mean effect of Qigong on depression was 0.38 (95% CI = 0.25 to 0.51). The heterogeneous mean effect of Tai Chi on anxiety was 0.34 (95% CI = 0.02 to 0.66); reductions were larger when participants were Asian and smaller when they were older. The heterogeneous mean effect of Qigong on anxiety was 0.72 (95% CI = 0.4 to 1.03); reductions were inversely related to age and positively related to session duration and weekly frequency. Conclusion Tai Chi and Qigong exercises have small-to-moderate efficacy for reducing symptoms of depression and anxiety. Higher-quality trials are needed that sample patients with elevated symptoms, use blinded allocation to conditions, and standardize Tai Chi and Qigong exposure in order to better determine clinical effectiveness and its modifiers.
    Mental Health and Physical Activity 09/2014; 7(3). DOI:10.1016/j.mhpa.2014.08.001
  • Source
    Archives of Iranian medicine 08/2014; 17(8):593-4. · 1.11 Impact Factor

Full-text (2 Sources)

Available from
Jun 3, 2014